GFAP levels were significantly increased in AD patients compared to patients without dementia, suggesting that blood GFAP concentrations rose at a higher rate in people who would go on to develop AD [4,7,8] (Table 1). The gene discussed is GFAP; the disease is Alzheimer disease.